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CD8
+
 T cell responses are necessary for immune control of simian immunodeficiency virus
(SIV). However, the key parameters that dictate antiviral potency remain elusive,
conceivably because most studies to date have been restricted to analyses of circulating
CD8
+
 T cells. We conducted a detailed clonotypic, functional, and phenotypic survey of
SIV-specific CD8
+
 T cells across multiple anatomical sites in chronically infected rhesus
macaques with high (>10,000 copies/mL plasma) or low burdens of viral RNA (<10,000
copies/mL plasma). No significant differences in response magnitude were identified across
anatomical compartments. Rhesus macaques with low viral loads (VLs) harbored higher
frequencies of polyfunctional CXCR5
+
 SIV-specific CD8
+
 T cells in various lymphoid
tissues and higher proportions of unique Gag-specific CD8
+
 T cell clonotypes in the
mesenteric lymph nodes relative to rhesus macaques with high VLs. In addition, public Gag-
specific CD8
+
 T cell clonotypes were more commonly shared across distinct anatomical
sites than the corresponding private clonotypes, which tended to form tissue-specific
repertoires, especially in the peripheral blood and the gastrointestinal tract. Collectively,
these data suggest that functionality and tissue localization are important determinants of
CD8
+
 T cell–mediated efficacy against SIV.
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Introduction
CD8+ T cells are required to control human immunodeficiency 
virus (HIV) and simian immunodeficiency virus (SIV) but large-
ly fail to protect infected humans and monkeys from eventual 
progression to AIDS (1). These lentiviruses replicate primarily in 
lymphoid tissues and preferentially infect CD4+ follicular help-
er T (TFH) cells (2). Elite control of HIV/SIV replication has been 
attributed to various qualitative properties of virus-specific CD8+ 
T cells (3–8), including the expression of CXCR5, which allows fol-
licular access and direct proximity to infected CD4+ TFH cells (2, 
9, 10). However, most studies to date have been limited to evalua-
tions of peripheral blood samples, which may not fully recapitulate 
the whole-body response to HIV/SIV.
Antigen-specific CD8+ T cell populations generally incorpo-
rate several clonotypes, defined by the expression of distinct T 
cell receptors (TCRs) (11, 12). The composite properties of these 
constituent clonotypes in turn dictate the overall functionality of 
a given antigen-specific CD8+ T cell population (13). In the con-
text of HIV/SIV, morphologically constrained repertoires directed 
against biologically variable epitopes have been associated with 
reproducible patterns of viral escape (14), whereas certain aspects 
of morphologically diverse repertoires directed against biologi-
cally constrained epitopes have been associated with protection, 
including the early mobilization of public clonotypes (15), which 
are commonly generated via convergent recombination and there-
fore occur in multiple individuals (16, 17), and the subsequent 
mobilization of cross-reactive private clonotypes (18). It nonethe-
less remains unclear how SIV-specific CD8+ T cells traffick in vivo 
to mediate these effects at sites of viral replication.
Recent work has identified discrete subsets of tissue-resident 
memory T cells, which occupy various epithelial, lymphoid, and 
mucosal sites (19–22) and differ from circulating memory T cells 
(23), constitutively expressing the C-type lectin CD69 and lacking 
the lymph node (LN) homing markers CCR7 and CD62L (24). In 
line with this concept of localized adaptive immunity, previous 
studies have revealed a degree of clonotypic disparity between cir-
culating and mucosal SIV-specific CD8+ T cells, both in the context 
of acute infection (25) and in response to vaccination (26). Similar-
ly, tissue-resident CD8+ T cells isolated from the LNs of elite con-
trollers in another study exhibited skewed clonotypic profiles rela-
tive to specificity-matched CD8+ T cells isolated from venous blood 
samples, whereas the corresponding CD69– HIV-specific CD8+ T 
cells were clonotypically similar across the same anatomical com-
partments (27). These data suggest that distinct clonotypes may 
occupy distinct tissue niches, but to date, a comprehensive survey 
has not been performed across multiple anatomical sites.
In this study, we compared the clonotypic, functional, and 
phenotypic characteristics of SIV-specific CD8+ T cells across 
matched samples of peripheral blood and various lymphoid 
and mucosal tissues isolated from chronically infected rhesus 
macaques with high (>10,000 RNA copies/mL plasma) or low 
viral loads (VLs) (<10,000 RNA copies/mL plasma). We found 
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In further analyses, we compared the phenotypes of lymphoid 
and mucosal SIV-specific CD8+ T cells, focusing on expression of 
the costimulatory molecules CD27 and CD28 and the tissue resi-
dency marker CD69. Strong correlations were detected between 
SIV-specific CD8+ T cells in the spleen and SIV-specific CD8+ 
T cells in the GI tract with respect to the expression frequencies 
of CD27 (Figure 1C) and CD28 (Figure 1D). No such association 
was observed for CD69 (Figure 1E). It was also noted that CD27, 
CD28, and CD69 were not differentially expressed on the surface 
of SIV-specific CD8+ T cells as a function of VL (data not shown).
Expression of CXCR5 on SIV-specific CD8+ T cells correlates 
inversely with VL. As expected, higher frequencies of CD4+ T cells 
in the GI tract and higher numbers of CD4+ T cells in the peripher-
al blood were detected in rhesus macaques with low VLs relative to 
rhesus macaques with high VLs (Figure 2, A and B). Moreover, the 
frequency of SIV-specific CD8+ T cells in the GI tract correlated 
with the frequency of CD4+ T cells in the GI tract and the number 
of CD4+ T cells in the peripheral blood (Figure 2, C and D).
Earlier work suggested that SIV-specific CD8+ T cells can enter 
lymphoid follicles in Asian macaques with low VLs (9, 10). In line 
with this observation, we found higher frequencies of CXCR5+ 
SIV-specific CD8+ T cells in the spleens of rhesus macaques with 
low VLs relative to rhesus macaques with high VLs (Figure 2E). To 
assess the biological relevance of this association, we measured 
SIV gag DNA in flow-sorted CD4+ TFH cells from the same tissues 
(Supplemental Figure 2). The frequency of CXCR5+ SIV-specific 
CD8+ T cells in the spleen correlated inversely with the amount 
of CD4+ TFH cell–associated viral DNA (Figure 2F) and the plasma 
burden of viral RNA (Figure 2G).
that public clonotypes were commonly shared across anatomical 
sites, whereas private clonotypes were more often tissue specific. 
In addition, we identified correlates of immune control, including 
the presence of polyfunctional CXCR5+ SIV-specific CD8+ T cells 
in lymphoid tissues, such as the spleen and various LNs.
Results
SIV-specific CD8+ T cells occur at similar frequencies in lymphoid 
and mucosal tissues. In preliminary experiments, we used fluoro-
chrome-labeled pentameric complexes of Mamu-A*01-CTPYD-
INQM Gag181–189 (CM9) and/or Mamu-A*02-YTSGPGIRY Nef159–167 
(Nef) and Mamu-A*02-GSENLKSLY Gag71–79 (Gag) to evaluate the 
distribution of SIV-specific CD8+ T cells across matched samples 
of peripheral blood and various tissue homogenates obtained from 
chronically infected rhesus macaques with high (>10,000 RNA 
copies/mL plasma; n = 16) or low VLs (<10,000 RNA copies/mL 
plasma; n = 6) (Table 1 and Supplemental Figure 1; supplemental 
material available online with this article; https://doi.org/10.1172/
JCI129161DS1). No significant anatomical differences in response 
magnitude were detected between or within these outcome- 
defined groups (Figure 1A). Accordingly, the frequency of SIV-spe-
cific CD8+ T cells in the spleen correlated with the frequencies of 
SIV-specific CD8+ T cells in the GI tract (Figure 1B), the peripheral 
blood, and the axillary/inguinal lymph nodes (ALNs/ILNs) (Table 
2). In contrast, the frequency of SIV-specific CD8+ T cells in the 
peripheral blood correlated only with the frequency of SIV-specific 
CD8+ T cells in the spleen, and the frequency of SIV-specific CD8+ 
T cells in the mesenteric lymph nodes (MLNs) correlated only with 
the frequency of SIV-specific CD8+ T cells in the GI tract (Table 2).
Table 1. Characteristics of rhesus macaques used in this study
Animal MHC genotype Virus Disease state CD4 countA Viral loadB Virologic status
Rh594 Mamu-A*01 smE543 Chronic 292 8,600 Low VL
Rh760 Mamu-A*01 smE543 Chronic 296 5,000 Low VL
Rh863 Mamu-A*01 smE660 Chronic 1,245 370 Low VL
Rh867 Mamu-A*01 smE660 Chronic 634 15 Low VL
Rh871 Mamu-A*01 smE660 Chronic 513 15 Low VL
RhF98 Mamu-A*01, Mamu-A*02 mac239 Chronic 560 15 Low VL
Rh591 Mamu-A*01 smE543 Chronic 186 251,000 High VL
Rh764 Mamu-A*01 smE543 Chronic 134 222,000 High VL
Rh766 Mamu-A*01 smE543 Chronic 927 50,000 High VL
Rh828 Mamu-A*01 smE543 Chronic 264 330,000 High VL
RhCL4C Mamu-A*01 mac239 AIDS 47 470,000 High VL
RhCL86 Mamu-A*01 mac239 AIDS 91 900,000 High VL
RhDB07 Mamu-A*02 mac239 Chronic 317 550,000 High VL
RhDB17 Mamu-A*02, Mamu-B*08 mac239 AIDS 122 92,000 High VL
RhDB92 Mamu-A*02 mac239 Chronic 256 100,000 High VL
RhDCBC Mamu-A*02 mac239 AIDS 14 1,200,000 High VL
RhDCJWA Mamu-A*02, Mamu-B*17 mac239 AIDS 509 810,000 High VL
RhDCKJ Mamu-A*02 mac239 AIDS 192 950,000 High VL
RhDE1A Mamu-A*02 mac239 AIDS 246 870,000 High VL
RhDE20 Mamu-A*02 mac239 AIDS 471 67,000 High VL
RhDE2W Mamu-A*02 mac239 AIDS 93 2,700,000 High VL
RhZA525 Mamu-A*02, Mamu-B*17 mac239 AIDS 133 1,300,000 High VL
ANumber of CD4+ T cells/μL blood. BCopies viral RNA/mL plasma. 
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lated at necropsy from each anatomical site in rhesus macaques 
with high (Supplemental Figure 3) or low VLs (Supplemental 
Figure 4). Data were normalized before analysis to correct for 
differences in sample size (29, 30). The number of unique clo-
notypes per anatomical site was similar in rhesus macaques 
with high (median 6, range 1–16) and low VLs (median 7, range 
1–13). Moreover, no consistent anatomical differences in reper-
toire diversity were apparent between or within these outcome- 
defined groups, and accordingly, no correlations were detected 
between repertoire diversity and either the amount of CD4+ TFH 
cell–associated viral DNA or the plasma burden of viral RNA 
(data not shown and Figure 4A). There were some conspicuous 
anatomical differences in repertoire similarity, however, most 
notably between lymphoid and mucosal sites in certain rhesus 
macaques with high or low VLs (Figure 4B).
SIV-specific CD8+ T cells are polyfunctional in rhesus macaques 
with low VLs. To extend these findings, we assessed the function-
ality of SIV-specific CD8+ T cells in response to cognate peptide 
stimulation, measuring surface mobilization of CD107a and the 
simultaneous induction of IFN-γ, IL-2, IL-21, and TNF-α. The 
inclusion of IL-21 in the readout was designed to identify TFH-like 
activity (28). Overall, SIV-specific CD8+ T cells were more poly-
functional in the ALNs/ILNs of rhesus macaques with low VLs rel-
ative to rhesus macaques with high VLs, but very few of these cells 
in either group produced IL-21 (Figure 3A).
In similar experiments, we compared the functionality of 
CXCR5+ and CXCR5– SIV-specific CD8+ T cells, measuring sur-
face mobilization of CD107a and intracellular granzyme B, IFN-γ, 
macrophage inflammatory protein–1β (MIP-1β), RANTES, and 
TNF-α. CXCR5+ SIV-specific CD8+ T cells were more polyfunc-
tional in the spleens of rhesus macaques with low VLs 
relative to rhesus macaques with high VLs and produced 
a wider range of effector molecules relative to CXCR5– 
SIV-specific CD8+ T cells (Figure 3B and Table 3).
SIV-specific CD8+ T cell clonotypes targeting CM9 
are structurally diverse. The early mobilization of pub-
lic clonotypes and the subsequent mobilization of 
cross-reactive private clonotypes directed against bio-
logically constrained epitopes have been associated 
with enhanced control of HIV/SIV (15, 18). We therefore 
used an unbiased molecular approach to characterize 
all expressed TCRβ locus (TRB) gene rearrangements 
in flow-sorted Mamu-A*01–restricted CM9-specific 
CD8+ T cell populations (Supplemental Figure 2) iso-
Figure 1. SIV-specific CD8+ T cells occur at similar frequencies in lymphoid and mucosal tissues. (A) Frequency of SIV-specific (CM9/Nef/Gag) CD8+ T cells 
across various anatomical sites. Horizontal bars indicate median values. GI, gastrointestinal. (B) Correlation between the frequency of SIV-specific CD8+ T 
cells in the GI tract and the frequency of SIV-specific CD8+ T cells in the spleen. (C–E) Frequency correlations for CD27+ (C), CD28+ (D), and CD69+ SIV-spe-
cific CD8+ T cells (E) in the GI tract versus the spleen. Data were acquired from Mamu-A*01+ and Mamu-A*02+ rhesus macaques (n = 22). Significance was 
determined using the Wilcoxon rank sum test (A) or Spearman’s rank correlation with linear regression (B–E).
Table 2. Frequency correlations for SIV-specific CD8+ T cells across various 
anatomical sites
Spleen ALN/ILN MLN GI tract
PBMC 0.6364, 0.0402 0.3736, 0.2562 0.4643, 0.3024 0.4273, 0.1928
Spleen 0.8196, 0.0017 0.6905, 0.0694 0.7680, <0.0001
ALN/ILN 0.6467, 0.0911 0.6830, 0.0171
MLN 0.9048, 0.0046
Data were acquired from Mamu-A*01+ and Mamu-A*02+ rhesus macaques (n = 22). 
Significance was determined using Spearman’s rank correlation with linear regression. 
Each cell shows the corresponding R (left) and P value (right). Details as in Figure 1B.
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5D). In general, the number of anatomical sites occupied by a 
given clonotype increased as the frequency of a given clonotype 
increased at any given anatomical site, and this was true across 
all sampled tissues (Figure 5E and Table 4). However, there were 
exceptions to this pattern, especially in the GI tract, where some 
clonotypes occurred at high frequencies with no sharing (e.g., 
rhesus macaque 591) or sharing restricted to the MLNs (e.g., 
rhesus macaque 863), and other clonotypes occurred at low fre-
quencies with sharing across all anatomical sites (e.g., rhesus 
macaques 760 and F98) (Figure 5, A and B). Moreover, approxi-
mately 40% of clonotypes were unique to each site, rising to more 
than 55% in the peripheral blood and the GI tract, and most of 
the shared clonotypes in the peripheral blood were found in the 
spleen but not in the GI tract (Figure 5F). These clonotypically 
distinct SIV-specific CD8+ T cell populations were nonetheless 
functionally equivalent across various tissue sites, at least after 
stimulation with nonlimiting concentrations of CM9 (Figure 5G).
Public clonotypes were identified on the basis of sharing at the 
amino acid level across more than 1 rhesus macaque in our cohort 
and/or across previously reported data sets from other rhesus 
macaques (refs. 14, 15, 31 and Figure 6, A and B). No significant 
differences in the anatomical distribution of public clonotypes 
were detected between or within groups (Figure 6C). However, 
public clonotypes with identical nucleotide sequences were shared 
across anatomical sites more commonly than private clonotypes in 
individual rhesus macaques, irrespective of VL (Figure 6D).
Discussion
Virus-specific CD8+ T cells are necessary for the control of HIV 
and SIV (32–34). However, the precise determinants of immune 
A vast majority of CM9-specific clonotypes in both groups 
incorporated CDR3β loops spanning 14 amino acids, with equiv-
alent representation at each anatomical site (Supplemental Fig-
ure 5). Irrespective of anatomical location, preferential use of 
TRBV6-1 and TRBV9 was observed in rhesus macaques with high 
VLs (Figure 4C), and preferential use of TRBV6-1, TRBV10-2, 
and TRBV13 was observed in rhesus macaques with low VLs 
(Figure 4D). Similarly, preferential use of TRBJ1-5 and TRBJ2-1 
was observed in rhesus macaques with high VLs (Supplemental 
Figure 6A), and preferential use of TRBJ1-5 was observed in rhe-
sus macaques with low VLs (Supplemental Figure 6B). No clear 
motifs were observed among non–germline-encoded CDR3β res-
idues, irrespective of VL (Figure 4, E and F).
SIV-specific CD8+ T cell clonotypes targeting CM9 are ana-
tomically discrete. To substantiate the observed anatomical dif-
ferences in repertoire similarity, we assessed the distribution 
of CM9-specific clonotypes across peripheral blood and tissue 
sites, again comparing rhesus macaques with high versus low 
VLs. A degree of clonotype sharing was apparent in each individ-
ual rhesus macaque, most notably between the spleen and the 
peripheral blood and between the MLNs and the GI tract (Figure 
5, A and B). However, many clonotypes were either unique to a 
particular anatomical site or preferentially located in a particu-
lar anatomical site, most commonly the GI tract (Figure 5, A and 
B). No obvious anatomical differences in clonotype sharing were 
detected between groups, although unique clonotypes were sig-
nificantly more common in the MLNs of rhesus macaques with 
low VLs relative to rhesus macaques with high VLs (Figure 5C). 
Equivalent levels of sharing between groups were also observed 
for clonotypes stratified by the number of occupied sites (Figure 
Figure 2. Expression of CXCR5 on SIV-specific CD8+ T cells correlates inversely with VL. (A) Frequency of CD4+ T cells in the GI tract. (B) Number of CD4+ 
T cells in the peripheral blood. (C) Correlation between the frequency of SIV-specific CD8+ T cells in the GI tract and the frequency of CD4+ T cells in the GI 
tract. (D) Correlation between the frequency of SIV-specific CD8+ T cells in the GI tract and the number of CD4+ T cells in the peripheral blood. (E) Frequency 
of CXCR5+ SIV-specific CD8+ T cells in the spleen. (F) Correlation between the frequency of CXCR5+ SIV-specific CD8+ T cells in the spleen and the amount 
of viral DNA in CD4+ TFH cells. (G) Correlation between the frequency of CXCR5+ SIV-specific CD8+ T cells in the spleen and VL. Data were acquired from 
Mamu-A*01+ and Mamu-A*02+ rhesus macaques (n = 22). Horizontal bars indicate median values (A, B, and E). Significance was determined using the 
Mann-Whitney U test (A, B, and E) or Spearman’s rank correlation with linear regression (C, D, F, and G).
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ential occurrence of CXCR5+ SIV-specific CD8+ T cells in rhesus 
macaques with low VLs. Follicular CXCR5+ SIV-specific CD8+ T 
cells are nonetheless optimally positioned to suppress viral replica-
tion in vivo, potentially via noncytolytic mechanisms (41).
Our current understanding of HIV/SIV-specific CD8+ T cell 
responses is derived mainly from studies of peripheral blood, 
which is easily accessible in humans and other primates (1, 3, 4, 
14, 15, 18, 32–34, 42). Other windows may provide better insights, 
however, because these viruses replicate in lymphoid tissues, 
and very few lymphocytes in the total body pool circulate at any 
efficacy remain unclear, potentially because current paradigms 
are based primarily on studies of circulating CD8+ T cells. We 
report here that SIV-specific CD8+ T cells are clonotypical-
ly distinct across multiple anatomical compartments in rhesus 
macaques with chronic infection or AIDS. Public clonotypes were 
commonly shared across anatomical sites in individual rhesus 
macaques, as were the more dominant clonotypes at any particu-
lar anatomical site, but overall, approximately 40% of clonotypes 
were site specific, and unique clonotypes were observed most 
often in the peripheral blood and the GI tract. Moreover, rhesus 
macaques with low VLs harbored higher frequencies of polyfunc-
tional CXCR5+ SIV-specific CD8+ T cells in various lymphoid tis-
sues, such as the spleen and the ALNs/ILNs.
Expression of CXCR5 is required for entry into B cell follicles 
(35, 36). We found that the frequency of CXCR5+ SIV-specific CD8+ 
T cells in the spleen correlated inversely with viral replication, mea-
sured in terms of CD4+ TFH cell–associated viral DNA and plasma 
viral RNA. Although these findings are consistent with the hypoth-
esis that follicular access licenses the optimal delivery of antiviral 
effector functions (37–39), it is important to note that high levels 
of antigen expression can exhaust follicular CXCR5+ virus-specific 
CD8+ T cells as a consequence of sustained activation via the TCR 
(40). This phenomenon may explain, at least in part, the prefer-
Figure 3. SIV-specific CD8+ T cells are polyfunc-
tional in rhesus macaques with low VLs. (A) Pie 
charts depict relative expression of CD107a, IFN-γ, 
IL-2, IL-21, and/or TNF-α among memory CD8+ 
T cells in response to stimulation of ALNs/ILNs 
with overlapping peptides spanning SIV Gag (n = 
6 Mamu-A*01+ rhesus macaques per group). (B) 
Pie charts depict relative expression of CD107a, 
granzyme B, IFN-γ, MIP-1β, RANTES, and/or 
TNF-α among CXCR5+ or CXCR5– memory CD8+ 
T cells in response to stimulation of splenocytes 
with overlapping peptides spanning SIV Gag (n = 4 
Mamu-A*01+ rhesus macaques per group). Signifi-
cance was determined using the permutation test 
in Simplified Presentation of Incredibly Complex 
Evaluations (SPICE) (detailed in Table 3).
Table 3. Functionality comparisons for CXCR5+ versus CXCR5– 
memory CD8+ T cells in rhesus macaques with high versus low VLs
Low VL CXCR5+ High VL CXCR5– Low VL CXCR5–
High VL CXCR5+ 0.0124 0.1132 0.0206
Low VL CXCR5+ 0.0278 0.2641
High VL CXCR5– 0.0583
Data were acquired from Mamu-A*01+ rhesus macaques (n = 4). 
Significance was determined using the permutation test in SPICE. Each cell 
shows the corresponding P value. Details as in Figure 3B.
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given time (43). In line with previous studies, we found a degree 
of clonotype sharing across anatomical compartments (25, 26, 
44), which has likewise been reported in the context of influen-
za virus infection (45). However, we also identified anatomically 
unique clonotypes, most frequently in the peripheral blood and 
the GI tract. The clonotypic disparity between peripheral blood 
and lymphoid tissues is consistent with the recent description 
of tissue-resident HIV-specific CD8+ T cells (27), which provide 
durable antiviral immunity at the site(s) of viral challenge/repli-
cation (27, 46, 47). Our data therefore suggest 2 mutually inclusive 
possibilities. The first is that individual CD8+ T cells are primed 
in situ and do not traffick extensively between anatomical com-
partments during chronic infection, implying that systemic vacci-
nation may be required to elicit long-term immunity against HIV/
SIV (26). The second is that public clonotypes are more readily 
primed during the early stages of infection as a function of preva-
lence within the naive pool, which can be attributed to convergent 
recombination (48, 49), and subsequently form highly stable tis-
sue-resident populations, which are then more likely to be shared 
across sites of viral replication (27, 50). Longitudinal studies will 
be necessary to address these possibilities and determine which 
route(s) of vaccine delivery are likely to favor the generation of 
effective immunity against HIV/SIV.
In summary, we have demonstrated that SIV-specific CD8+ 
T cells are clonotypically, functionally, and phenotypically dis-
tinct across multiple anatomical sites in outcome-defined groups 
of rhesus macaques with chronic infection or AIDS. A greater 
understanding of these anatomical complexities may therefore 
be required to identify the key attributes of effective virus-specif-
ic CD8+ T cell responses, which in turn may inform the rational 
design of next-generation vaccines against HIV/SIV.
Methods
Study design. The goal of this study was to assess the functional and 
phenotypic characteristics of SIV-specific CD8+ T cell clonotypes 
across distinct anatomical compartments in rhesus macaques (Macaca 
Figure 4. Clonotypic architecture of CM9-specific CD8+ T cell populations. (A) Repertoire diversity in rhesus macaques with high (n = 6) or low VLs (n = 
6). (B) Repertoire similarity in rhesus macaques with high (n = 6) or low VLs (n = 6). (C) TRBV gene use in rhesus macaques with high VLs (n = 6). (D) TRBV 
gene use in rhesus macaques with low VLs (n = 6). (E) CDR3β amino acid use in rhesus macaques with high VLs (n = 6). (F) CDR3β amino acid use in rhesus 
macaques with low VLs (n = 6). Significance was determined using the permutation test in SPICE (C and D).
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mulatta) with high (>10,000 RNA copies/mL plasma; n = 16) or low 
VLs (<10,000 RNA copies/mL plasma; n = 6) during the chronic phase 
of infection with SIVmac239, SIVsmE543, or SIVsmE660 (Table 1 and 
Supplemental Figure 1). Selection criteria included the availability 
of cryopreserved tissue homogenates. PBMCs, spleen, ALNs, ILNs, 
MLNs, colon, and jejunum were obtained at necropsy from Mamu-A*01+ 
(n = 12) and Mamu-A*02+ rhesus macaques (n = 11) with established SIV 
infection or AIDS (Table 1). Samples were homogenized as described 
previously (51). Clinical endpoints were defined as (a) weight loss more 
than 25%; (b) major organ failure or medical conditions unresponsive 
to treatment; (c) complete anorexia for 4 days; (d) inability to consume 
sufficient nutrients to maintain body weight without assistance for 7 
days; (e) distress vocalization unresponsive to intervention for 7 days; 
and/or (f) tumors arising from other than experimental means that 
impaired movement, ulcerated, or grew to more than 10% of body 
weight. Euthanasia was performed according to guidelines established 
by the American Veterinary Medical Association.
Flow cytometric sorting of SIV-specific CD8+ T cells. Tissue homog-
enates were washed twice in RPMI 1640 medium supplemented with 
10% fetal bovine serum, 2 mM L-glutamine, and 1% penicillin/strep-
tomycin (all from HyClone, GE Healthcare Life Sciences). SIV-specif-
ic CD8+ T cells were identified using CM9 and/or Nef and Gag Pro5 
MHC Class I Pentamers (ProImmune). Surface markers were iden-
tified using pretitrated concentrations of the following antibodies: 
(a) anti-CD8a (RPA-T8) and anti-CXCR5 (MU5UBEE) from eBio-
science; (b) anti-CD3 (SP34-2), anti-CD8a (SK1), anti-CD27 (O323), 
anti-CD69 (FN50), and anti-CCR7 (3D12) from BD Biosciences; (c) 
anti-CD4 (OKT4), anti-CD95 (DX2), and anti–PD-1 (EH12.2H7) from 
Figure 5. CM9-specific CD8+ T cell clonotypes are anatomically discrete. (A) Frequency of individual clonotypes across various anatomical sites in rhesus 
macaques with high VLs. (B) Frequency of individual clonotypes across various anatomical sites in rhesus macaques with low VLs. (C) Proportion of clono-
types detected in 1 (unique) or more than 1 (shared) anatomical site in rhesus macaques with high (n = 6) or low VLs (n = 6). Significance was determined 
using the χ2 test. **P < 0.01. (D) Proportion of clonotypes shared across the indicated number of anatomical sites in rhesus macaques with high (n = 6) 
or low VLs (n = 6). Significance was determined using the Mann-Whitney U test. (E) Correlation between the number of occupied anatomical sites and 
clonotype frequency in the GI tract. Significance was determined using Spearman’s rank correlation with linear regression. (F) Schematic representation 
of clonotype sharing across distinct anatomical sites (n = 12 Mamu-A*01+ rhesus macaques). Values in parentheses refer to unique clonotypes at each 
anatomical site (%). (G) Pie charts depict relative expression of CD107a, IFN-γ, MIP-1β, RANTES, and/or TNF-α among clonotypically distinct (TCR Vβ1+ 
or TCR Vβ23+) CM9-specific memory CD8+ T cells in response to stimulation of various tissue homogenates with overlapping peptides spanning SIV Gag 
(n = 4 Mamu-A*01+ rhesus macaques per group). Clonotypes found in multiple tissues (circulating) were distinguished from clonotypes found in 1 tissue 
(resident). Significance was determined using the permutation test in SPICE.
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Functional analysis of SIV-specific CD8+ T cells. Cell suspensions were 
stimulated with a pool of peptides spanning SIV Gag (15-mers overlap-
ping by 11 amino acids) at a final concentration of 2 μg/peptide/106 
cells in the presence of anti-CD28 (CD28.2; Beckman Coulter), anti-
CD107a (H4A3; BioLegend), brefeldin A (1 μg/mL; MilliporeSigma), 
and monensin (1 μg/mL; BD Biosciences) for 16 hours at 37°C. After 
stimulation, cells were washed in PBS, stained for surface markers, 
fixed/permeabilized, and stained for intracellular markers. The follow-
ing antibodies were used in these experiments: (a) anti-CD4 (OKT4), 
anti-CXCR5 (MU5UBEE), and anti–IL-21 (3A3-N2) from eBioscience; 
(b) anti-CD3 (SP34-2), anti-CD8a (SK1), anti-CD95 (DX2), anti–gran-
zyme B (GB11), anti–IL-2 (MQ1-17H12), anti–MIP-1β (D21-1351), and 
anti-RANTES (2D5) from BD Biosciences; (c) anti–IFN-γ (4S.B3) and 
anti–TNF-α (MAb11) from BioLegend; and (d) anti–TCR Vβ1 (BL37.2) 
and anti–TCR Vβ23 (AF23) from Beckman Coulter. Data were acquired 
using an LSR Fortessa (BD Biosciences). SIV-specific CD8+ T cells were 
defined as live, CD3+, CD8+, function+/pentamer+ lymphocytes (Sup-
plemental Figure 2). Functional profiles were analyzed using SPICE 
v5.35 (National Institute of Allergy and Infectious Diseases).
Quantification of cell-associated SIV DNA. SIV DNA was quan-
tified in CD4+ TFH cells as described previously (52, 53). Briefly, 
BioLegend; and (d) anti-CD28 (CD28.2) from Beckman Coulter. Bulk 
CD4+ TFH cells and SIV-specific CD8+ T cells were flow-sorted using 
a FACSAria (BD Biosciences). Bulk CD4+ TFH cells were defined as 
live, CD3+, CD4+, CD28+, CD95+, CXCR5+, PD-1+ lymphocytes, and 
SIV-specific CD8+ T cells were defined as live, CD3+, CD8+, CM9/Nef/
Gag+ lymphocytes (Supplemental Figure 2).
Table 4. Correlations between the number of occupied anatomical 
sites and clonotype frequency at each anatomical site
Tissue R P
PBMC 0.4470 <0.0001
Spleen 0.5621 <0.0001
ALN/ILN 0.4718 <0.0001
MLN 0.5074 0.0003
GI tract 0.4217 0.0002
Data were acquired from Mamu-A*01+ rhesus macaques (n = 12). 
Significance was determined using Spearman’s rank correlation with linear 
regression. Details as in Figure 5E. 
Figure 6. Public CM9-specific CD8+ 
T cell clonotypes are commonly 
shared across multiple anatomi-
cal sites. (A) Frequency of public 
(colored bars) or private clonotypes 
(white bars) across various anatom-
ical sites in rhesus macaques with 
high VLs. (B) Frequency of public 
(colored bars) or private clonotypes 
(white bars) across various anatom-
ical sites in rhesus macaques with 
low VLs. (C) Proportion of public or 
private clonotypes detected at each 
anatomical site in rhesus macaques 
with high (n = 6) or low VLs (n = 6). 
Significance was determined using 
the χ2 test. (D) Proportion of public or 
private clonotypes shared across the 
indicated number of anatomical sites 
in Mamu-A*01+ rhesus macaques (n 
= 12). Significance was determined 
using the Mann-Whitney U test.
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U test. Correlations were evaluated using Spearman’s rank correlation 
with linear regression. Proportions were compared using the χ2 test. 
All statistical analyses were performed using Prism v7.0 (GraphPad 
Software Inc.). P values less than 0.05 were considered significant. 
Functional profiles were compared using the permutation test with 
relative expression values in SPICE v5.35 (National Institute of Allergy 
and Infectious Diseases).
Study approval. Experimental procedures were approved by the 
National Institute of Allergy and Infectious Diseases Division of Intra-
mural Research Animal Care and Use Program as part of the NIH 
Intramural Research Program (protocols LMM6 and LVD26). Rhesus 
macaques were housed and sustained in accordance with standards 
established by the Association for Assessment and Accreditation of 
Laboratory Animal Care.
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flow-sorted cells were lyzed using 25 μL of a 1:100 dilution of pro-
teinase K (Roche) in 10 mM Tris-HCl (pH 8.4). Quantitative PCRs 
were performed in duplicate using 5 μL of cell lysate per reaction 
with TaqMan Master Mix (Thermo Fisher Scientific) over 50 cycles 
of 95°C for 15 seconds and 60°C for 1 minute after a single holding 
step of 95°C for 5 minutes. SIVmac239 gag was amplified using the for-
ward primer GTCTGCGTCATYTGGTGCATTC and the reverse 
primer CACTAGYTGTCTCTGCACTATRTGTTTTG with the probe 
CTTCRTCAGTYTGTTTCACTTTCTCTTCTGCG. SIVsmE543/smE660 gag 
was amplified using the forward primer GGCAGGAAAATCCCTAG-
CAG and the reverse primer GCCCTTACTGCCTTCACTCA with the 
probe AGTCCCTGTTCRGGCGCCAA. Cell numbers were quanti-
fied relative to monkey albumin (54). Reactions were processed using 
a StepOnePlus Real-Time PCR System (Applied Biosystems, Thermo 
Fisher Scientific), and template copies were calculated using StepOne 
Software (Applied Biosystems, Thermo Fisher Scientific).
Clonotype analysis. Pentamer-labeled CD8+ T cells were flow-sort-
ed viably into 100 μL of RNAlater (MilliporeSigma). All expressed 
TRB gene rearrangements were amplified without bias using a tem-
plate-switch anchored reverse transcription PCR as described previ-
ously (55). Sequences were aligned using Sequencher v5.4.6 (Gene 
Codes Corporation). TRBV and TRBJ genes were identified accord-
ing to the ImMunoGeneTics nomenclature (56). Data were normal-
ized using a randomization procedure to account for differences in 
sample size as described previously (29, 30). Repertoire diversity 
was assessed using the Shannon diversity index (29), and repertoire 
similarity was assessed using the Morisita-Horn similarity index (30). 
Anatomical overlap was visualized using Circos (http://circos.ca/) and 
InteractiVenn (http://www.interactivenn.net/), and amino acid use 
was visualized using WebLogo (https://weblogo.berkeley.edu/).
Statistics. Matched groups were compared using the Wilcoxon rank 
sum test. Unmatched groups were compared using the Mann-Whitney 
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